Comparison of the pharmacokinetics of entecavir in HBV mono-infected and HIV/HBV co-infected subjects using population pharmacokinetic modeling.

被引：0
|
作者：
Xu, X. [1 ]
Zhu, M. [1 ]
Yan, J. [1 ]
Bifano, M. [1 ]
Wang, Y. [1 ]
Setiadi, O. [1 ]
LaCreta, F. [1 ]
Grasela, D. [1 ]
Pfister, M. [1 ]
机构：
[1] Bristol Myers Squibb Co, Princeton, NJ USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2007年 / 81卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：S98 / S98
页数：1
相关论文
共 50 条
  • [21] Detectable HBV viraemia in HIV/HBV co-infected patients undergoing HBV active antiretroviral therapy
    Morsica, G.
    Lolatto, R.
    Bertoni, C.
    Siribelli, A.
    Bottanelli, M.
    Hasson, H.
    Castagna, A.
    Uberti-Foppa, C.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2022, 25 : 186 - 186
  • [22] Prevalence and characterisation of lamivudine resistant HBV mutations in HIV and HBV co-infected individuals
    Cooley, L
    Ayres, A
    Lewin, S
    Crowe, S
    Mijch, A
    Roberts, S
    Locarnini, SA
    Sasadeusz, J
    HEPATOLOGY, 2002, 36 (04) : 640A - 640A
  • [23] Management of hepatitis C in HIV and/or HBV co-infected patients
    Vicente Fernandez-Montero, Jose
    Soriano, Vicente
    BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2012, 26 (04) : 517 - 530
  • [24] LOSS OF SURFACE ANTIGEN IN HIV/HBV CO-INFECTED INDIVIDUALS
    Dieterich, Douglas T.
    Fusco, Jennifer
    Russo, Mark W.
    Brunet, Laurence
    Fusco, Gregory P.
    HEPATOLOGY, 2019, 70 : 593A - 594A
  • [25] Hepatocellular carcinoma in patient co-infected with HIV, HBV, and HCV
    Ahmed, Ali
    Yen, Roy
    Rani, Abha
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2008, 103 : S121 - S122
  • [26] Entecavir plus lamivudine as an alternative treatment for co-infected HBV/HIV patients with toxicity on tenofovir therapy
    Fontecha-Ortega, Maria
    Munoz-Mendoza, Vanesa
    Monsalvo, Marta
    Mateos, Marisa
    Angel Rodriguez-Sagrado, Miguel
    Gomez, Cristina
    Luis Casado, Jose
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2016, 19
  • [27] The HIV/HBV co-infected patient: Time for proactive management
    Andersson, M. I.
    Preiser, W.
    van Rensburg, C.
    Taljaard, J.
    Hoffmann, C. J.
    SAMJ SOUTH AFRICAN MEDICAL JOURNAL, 2015, 105 (04): : 281 - 282
  • [28] Disseminated Emmonsia in an HIV-HBV co-infected man
    Mutyaba, Arthur
    Sonderup, Mark W.
    Locketz, Michael
    Okpechi, Ikechi
    Spearman, C. Wendy
    Tooke, Alan
    IDCASES, 2015, 2 (02): : 35 - 36
  • [29] Detection of Hepatitis B Virus (HBV) Genomes and HBV Drug Resistant Variants by Deep Sequencing Analysis of HBV Genomes in Immune Cell Subsets of HBV Mono-Infected and/or Human Immunodeficiency Virus Type-1 (HIV-1) and HBV Co-Infected Individuals
    Lee, Z.
    Nishikawa, S.
    Gao, S.
    Eksteen, J. B.
    Czub, M.
    Gill, M. J.
    Osiowy, C.
    van der Meer, F.
    van Marle, G.
    Coffin, C. S.
    PLOS ONE, 2015, 10 (09):
  • [30] Comparison of Cytokine Expression Profile in Chikungunya and Dengue Co-Infected and Mono-Infected Patients' Samples
    Krishnan, Saravana Murali
    Mahalingam, Jayashri
    Sabarimurugan, Shanthi
    Muthu, Thiruvengadam
    Venkidasamy, Baskar
    Krishnasamy, Kaveri
    Sharma, Ashutosh
    Ramalingam, Sathishkumar
    PATHOGENS, 2021, 10 (02): : 1 - 13
12345